Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $159.6400 (-1.25%) ($158.3000 - $162.4200) on Tue. Jan. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 40 | Latest Price | $159.6400(-1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(22%) IBB(21%) SPLV(19%) XLP(18%) VYM(17%) | Factors Impacting ABBV price | ABBV will decline at least -0.565% in a week (0% probabilities). XLC(-13%) IPO(-13%) EDOC(-9%) BWX(-8%) VXX(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | -1.2 () | Intraday Trend | -1.6% | | | |
|
Resistance Level | $162.65 | 5 Day Moving Average | $163.01(-2.07%) | 10 Day Moving Average | $162.66(-1.86%) | 20 Day Moving Average | $162.65(-1.85%) | To recent high | -4.1% | To recent low | 15.4% | Market Cap | $281.65b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |